Items Tagged ‘David Knopman’
October 26, 2020
Mayo Clinic Research in the news — 10/26/2020
At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]
Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia
March 30, 2020
Mayo Clinic Research in the News — Week in Review 3/30/2020
In this unconventional time, we are going to offer an unconventional article, really a collection of the previous week’s news stories related to Mayo Clinic Research. Our plan – to share a brief excerpt and link to stories written by journalists around the world. Most will likely be about COVID-19, some may report findings that […]
Tags: antiviral, cardiology, clinical trials, collaboration, COVID-19, David Knopman, dementia, Gianrico Farrugia, heart attack, John Halamka, Mayo Clinic Laboratories, Mayo Clinic Proceedings
November 13, 2019
By Advancing the Science contributor 
By Mass General Research Communications Staff Stroke is the leading cause of adult disability in the US, with up to 70% of stroke survivors suffering some degree of post-stroke VCID. Furthermore, some stroke subtypes carry a disproportionate burden of the disability related to stroke. We are excited to announce that, last month, the National Institute […]
Tags: aging, Clifford Jack Jr., cognitive impairment, collaboration, David Knopman, dementia, James Meschia, Jonathan Graff-Radford, Kevin Barrett, Mayo Clinic Study of Aging, neurology, Prashanthi Vemuri
July 24, 2018
Mayo scientists presenting at Alzheimer’s Association conference
About 30 Mayo Clinic scientists are presenting at this week’s Alzheimer’s Association International Conference in Chicago, and another roughly two dozen researchers are contributing authors. They’re among more than 5,600 scientists from 65 countries. The schedule and abstracts are available on the Alzheimer’s Association conference website. All the research has one goal: to help the growing […]
Tags: Alzheimer's disease, David Knopman, David T. Jones, Guojun Bu, Kejal Kantarci, Mayo Clinic Study of Aging, Prashanthi Vemuri, Rochester Epidemiology Project, Ronald Petersen